| 13.6 |
40.7 |
GO:0002148 |
hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
| 7.2 |
21.6 |
GO:0030221 |
basophil differentiation(GO:0030221) |
| 5.6 |
45.0 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 5.5 |
16.6 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 5.4 |
16.3 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 5.0 |
15.1 |
GO:1903116 |
positive regulation of actin filament-based movement(GO:1903116) |
| 4.2 |
12.6 |
GO:0070947 |
neutrophil mediated killing of fungus(GO:0070947) |
| 4.2 |
12.5 |
GO:0060217 |
hemangioblast cell differentiation(GO:0060217) |
| 3.8 |
7.7 |
GO:0060931 |
sinoatrial node cell development(GO:0060931) |
| 3.8 |
7.5 |
GO:0031938 |
regulation of chromatin silencing at telomere(GO:0031938) |
| 3.8 |
3.8 |
GO:2000277 |
positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
| 3.7 |
22.1 |
GO:1902732 |
positive regulation of chondrocyte proliferation(GO:1902732) |
| 3.6 |
10.9 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 3.6 |
28.4 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 3.5 |
10.6 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 3.5 |
20.7 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 3.4 |
3.4 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 3.3 |
13.3 |
GO:0002540 |
leukotriene production involved in inflammatory response(GO:0002540) |
| 3.2 |
9.7 |
GO:0072299 |
negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 3.2 |
16.1 |
GO:0072236 |
metanephric loop of Henle development(GO:0072236) |
| 3.2 |
18.9 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 3.1 |
12.5 |
GO:0045575 |
basophil activation(GO:0045575) |
| 3.1 |
9.4 |
GO:0072138 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 3.1 |
15.5 |
GO:0010956 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
| 3.1 |
3.1 |
GO:0070099 |
regulation of chemokine-mediated signaling pathway(GO:0070099) |
| 3.1 |
12.4 |
GO:1904800 |
regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
| 3.0 |
14.9 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 2.9 |
14.6 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 2.9 |
8.8 |
GO:0032690 |
negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 2.9 |
8.8 |
GO:0045660 |
positive regulation of neutrophil differentiation(GO:0045660) |
| 2.8 |
8.5 |
GO:0090481 |
pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 2.8 |
2.8 |
GO:0060022 |
hard palate development(GO:0060022) |
| 2.8 |
11.2 |
GO:0098795 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 2.8 |
13.9 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 2.7 |
8.2 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 2.6 |
18.5 |
GO:0030421 |
defecation(GO:0030421) |
| 2.6 |
2.6 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 2.6 |
7.7 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 2.6 |
10.3 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 2.5 |
10.2 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 2.5 |
2.5 |
GO:0072166 |
posterior mesonephric tubule development(GO:0072166) |
| 2.5 |
7.6 |
GO:0033861 |
negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 2.5 |
7.4 |
GO:0046882 |
negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
| 2.5 |
7.4 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 2.4 |
2.4 |
GO:0050748 |
negative regulation of lipoprotein metabolic process(GO:0050748) |
| 2.4 |
2.4 |
GO:1905204 |
regulation of connective tissue replacement(GO:1905203) negative regulation of connective tissue replacement(GO:1905204) |
| 2.4 |
19.2 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 2.4 |
7.1 |
GO:0072382 |
minus-end-directed vesicle transport along microtubule(GO:0072382) |
| 2.3 |
30.2 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 2.3 |
7.0 |
GO:2000295 |
regulation of hydrogen peroxide catabolic process(GO:2000295) |
| 2.3 |
6.9 |
GO:0051714 |
regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
| 2.3 |
9.2 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 2.3 |
9.2 |
GO:0051944 |
positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 2.3 |
9.1 |
GO:0061146 |
Peyer's patch morphogenesis(GO:0061146) |
| 2.3 |
40.9 |
GO:0015816 |
glycine transport(GO:0015816) |
| 2.3 |
18.0 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 2.2 |
11.2 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 2.2 |
35.6 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 2.2 |
6.6 |
GO:1903367 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 2.2 |
6.5 |
GO:0031283 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 2.2 |
8.6 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 2.1 |
15.0 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 2.1 |
4.3 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 2.1 |
6.4 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 2.1 |
6.4 |
GO:0002277 |
myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 2.1 |
6.4 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
| 2.1 |
8.4 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 2.1 |
4.2 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 2.1 |
2.1 |
GO:1901608 |
regulation of vesicle transport along microtubule(GO:1901608) |
| 2.1 |
8.2 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 2.0 |
8.2 |
GO:0002752 |
cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 2.0 |
6.0 |
GO:0014064 |
positive regulation of serotonin secretion(GO:0014064) |
| 2.0 |
4.0 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 2.0 |
10.0 |
GO:0071694 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 2.0 |
10.0 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 2.0 |
7.9 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 2.0 |
2.0 |
GO:0033624 |
negative regulation of integrin activation(GO:0033624) |
| 2.0 |
7.9 |
GO:0048769 |
sarcomerogenesis(GO:0048769) |
| 1.9 |
9.7 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 1.9 |
1.9 |
GO:0072284 |
metanephric S-shaped body morphogenesis(GO:0072284) |
| 1.9 |
9.6 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 1.9 |
9.6 |
GO:0035989 |
tendon development(GO:0035989) |
| 1.9 |
3.8 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 1.9 |
5.7 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 1.9 |
1.9 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 1.9 |
5.6 |
GO:0061743 |
motor learning(GO:0061743) |
| 1.9 |
5.6 |
GO:0001983 |
baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 1.8 |
5.5 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 1.8 |
7.4 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.8 |
5.5 |
GO:0045004 |
DNA replication proofreading(GO:0045004) |
| 1.8 |
5.5 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 1.8 |
1.8 |
GO:1904008 |
response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 1.8 |
5.5 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 1.8 |
7.3 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 1.8 |
3.6 |
GO:0060031 |
mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
| 1.8 |
10.8 |
GO:0034441 |
plasma lipoprotein particle oxidation(GO:0034441) |
| 1.8 |
7.2 |
GO:1903288 |
positive regulation of potassium ion import(GO:1903288) |
| 1.8 |
9.0 |
GO:1900619 |
acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
| 1.8 |
7.2 |
GO:0015840 |
urea transport(GO:0015840) |
| 1.8 |
8.9 |
GO:0070944 |
neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 1.8 |
5.3 |
GO:0090191 |
negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 1.8 |
1.8 |
GO:0035854 |
eosinophil fate commitment(GO:0035854) |
| 1.8 |
7.1 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 1.8 |
5.3 |
GO:1904956 |
regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 1.8 |
7.0 |
GO:0060032 |
notochord regression(GO:0060032) |
| 1.7 |
5.2 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 1.7 |
3.5 |
GO:0001698 |
gastrin-induced gastric acid secretion(GO:0001698) |
| 1.7 |
5.1 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 1.7 |
17.1 |
GO:0030886 |
negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 1.7 |
5.1 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 1.7 |
10.2 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 1.7 |
17.0 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 1.7 |
8.5 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 1.7 |
1.7 |
GO:0021623 |
oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 1.7 |
11.6 |
GO:0010694 |
positive regulation of alkaline phosphatase activity(GO:0010694) |
| 1.6 |
4.9 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 1.6 |
6.6 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 1.6 |
3.3 |
GO:0042983 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 1.6 |
4.9 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 1.6 |
6.5 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 1.6 |
4.8 |
GO:0032972 |
regulation of muscle filament sliding speed(GO:0032972) |
| 1.6 |
9.6 |
GO:1900204 |
pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) kidney field specification(GO:0072004) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) |
| 1.6 |
4.7 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 1.6 |
1.6 |
GO:0035566 |
regulation of metanephros size(GO:0035566) |
| 1.6 |
3.2 |
GO:0002582 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.6 |
6.3 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 1.6 |
1.6 |
GO:2000388 |
positive regulation of ovarian follicle development(GO:2000386) regulation of antral ovarian follicle growth(GO:2000387) positive regulation of antral ovarian follicle growth(GO:2000388) |
| 1.6 |
1.6 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 1.6 |
4.7 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 1.6 |
4.7 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 1.5 |
6.2 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.5 |
6.2 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 1.5 |
21.6 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 1.5 |
3.1 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 1.5 |
1.5 |
GO:0072235 |
metanephric part of ureteric bud development(GO:0035502) distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) |
| 1.5 |
6.1 |
GO:0035470 |
positive regulation of vascular wound healing(GO:0035470) regulation of vascular wound healing(GO:0061043) |
| 1.5 |
4.5 |
GO:0050929 |
corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 1.5 |
7.5 |
GO:0036414 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.5 |
3.0 |
GO:0045658 |
regulation of neutrophil differentiation(GO:0045658) |
| 1.5 |
4.5 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 1.5 |
6.0 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 1.5 |
3.0 |
GO:0072162 |
metanephric mesenchymal cell differentiation(GO:0072162) |
| 1.5 |
11.9 |
GO:0030220 |
platelet formation(GO:0030220) |
| 1.5 |
1.5 |
GO:0061438 |
renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
| 1.5 |
16.2 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 1.5 |
4.4 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 1.5 |
4.4 |
GO:0009233 |
menaquinone metabolic process(GO:0009233) |
| 1.5 |
23.5 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 1.5 |
5.9 |
GO:0086045 |
membrane depolarization during AV node cell action potential(GO:0086045) |
| 1.5 |
1.5 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 1.4 |
21.7 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 1.4 |
1.4 |
GO:0090314 |
positive regulation of protein targeting to membrane(GO:0090314) |
| 1.4 |
5.8 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 1.4 |
1.4 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) |
| 1.4 |
2.9 |
GO:0071663 |
granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 1.4 |
8.6 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 1.4 |
1.4 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 1.4 |
4.3 |
GO:0014718 |
positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 1.4 |
1.4 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 1.4 |
2.8 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 1.4 |
4.2 |
GO:0071314 |
cellular response to cocaine(GO:0071314) |
| 1.4 |
9.8 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 1.4 |
7.0 |
GO:0002554 |
serotonin secretion by platelet(GO:0002554) |
| 1.4 |
4.2 |
GO:2000768 |
glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 1.4 |
7.0 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 1.4 |
15.3 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) |
| 1.4 |
6.9 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 1.4 |
5.5 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 1.4 |
2.7 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 1.4 |
12.2 |
GO:1900264 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 1.4 |
10.9 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 1.3 |
8.1 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 1.3 |
1.3 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 1.3 |
2.7 |
GO:0072053 |
renal inner medulla development(GO:0072053) |
| 1.3 |
1.3 |
GO:0071727 |
response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 1.3 |
25.4 |
GO:0007614 |
short-term memory(GO:0007614) |
| 1.3 |
5.3 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 1.3 |
4.0 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 1.3 |
1.3 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 1.3 |
2.7 |
GO:0042231 |
interleukin-13 biosynthetic process(GO:0042231) |
| 1.3 |
6.6 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 1.3 |
2.6 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 1.3 |
1.3 |
GO:0032741 |
positive regulation of interleukin-18 production(GO:0032741) |
| 1.3 |
10.5 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 1.3 |
3.9 |
GO:2000474 |
regulation of opioid receptor signaling pathway(GO:2000474) |
| 1.3 |
10.4 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 1.3 |
6.5 |
GO:1905171 |
protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
| 1.3 |
3.9 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 1.3 |
3.9 |
GO:0000912 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 1.3 |
6.5 |
GO:0014724 |
regulation of twitch skeletal muscle contraction(GO:0014724) |
| 1.3 |
3.9 |
GO:0098971 |
anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
| 1.3 |
13.0 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 1.3 |
9.1 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 1.3 |
7.8 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 1.3 |
3.9 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.3 |
2.6 |
GO:0001807 |
regulation of type IV hypersensitivity(GO:0001807) |
| 1.3 |
2.6 |
GO:0051795 |
positive regulation of catagen(GO:0051795) |
| 1.3 |
12.8 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 1.3 |
2.6 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 1.3 |
2.5 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 1.3 |
7.6 |
GO:0060023 |
soft palate development(GO:0060023) |
| 1.3 |
1.3 |
GO:0050923 |
regulation of negative chemotaxis(GO:0050923) |
| 1.3 |
7.6 |
GO:0002283 |
neutrophil activation involved in immune response(GO:0002283) |
| 1.3 |
3.8 |
GO:0002343 |
peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
| 1.3 |
5.0 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 1.3 |
22.6 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 1.3 |
2.5 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 1.3 |
5.0 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 1.2 |
3.7 |
GO:1902219 |
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 1.2 |
3.7 |
GO:0036022 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 1.2 |
19.8 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 1.2 |
1.2 |
GO:0051794 |
regulation of catagen(GO:0051794) |
| 1.2 |
6.2 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 1.2 |
2.5 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 1.2 |
1.2 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 1.2 |
1.2 |
GO:0032329 |
serine transport(GO:0032329) |
| 1.2 |
1.2 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 1.2 |
3.7 |
GO:0039692 |
single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
| 1.2 |
3.7 |
GO:0034163 |
regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
| 1.2 |
3.7 |
GO:0042494 |
detection of bacterial lipoprotein(GO:0042494) |
| 1.2 |
2.4 |
GO:0061209 |
cell proliferation involved in mesonephros development(GO:0061209) regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 1.2 |
3.6 |
GO:0098763 |
mitotic cell cycle phase(GO:0098763) |
| 1.2 |
3.6 |
GO:0071846 |
actin filament debranching(GO:0071846) |
| 1.2 |
1.2 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.2 |
4.8 |
GO:0038094 |
Fc-gamma receptor signaling pathway(GO:0038094) |
| 1.2 |
2.4 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 1.2 |
3.6 |
GO:0035054 |
embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 1.2 |
2.4 |
GO:0002019 |
regulation of renal output by angiotensin(GO:0002019) |
| 1.2 |
3.6 |
GO:0002030 |
inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
| 1.2 |
3.5 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 1.2 |
3.5 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 1.2 |
3.5 |
GO:0051934 |
dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
| 1.2 |
9.4 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 1.2 |
2.3 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 1.2 |
3.5 |
GO:0051466 |
corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 1.2 |
3.5 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 1.2 |
4.6 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 1.2 |
1.2 |
GO:1990773 |
regulation of matrix metallopeptidase secretion(GO:1904464) matrix metallopeptidase secretion(GO:1990773) |
| 1.1 |
1.1 |
GO:1902302 |
regulation of potassium ion export(GO:1902302) |
| 1.1 |
4.6 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 1.1 |
1.1 |
GO:1903056 |
regulation of melanosome organization(GO:1903056) |
| 1.1 |
1.1 |
GO:0031335 |
regulation of sulfur amino acid metabolic process(GO:0031335) |
| 1.1 |
1.1 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 1.1 |
4.6 |
GO:0030070 |
insulin processing(GO:0030070) |
| 1.1 |
1.1 |
GO:0090172 |
microtubule cytoskeleton organization involved in homologous chromosome segregation(GO:0090172) |
| 1.1 |
4.5 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 1.1 |
9.0 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 1.1 |
21.4 |
GO:0038065 |
collagen-activated signaling pathway(GO:0038065) |
| 1.1 |
3.4 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 1.1 |
6.7 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.1 |
4.5 |
GO:0042222 |
interleukin-1 biosynthetic process(GO:0042222) |
| 1.1 |
1.1 |
GO:0099552 |
trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 1.1 |
3.3 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 1.1 |
4.4 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.1 |
7.7 |
GO:1990169 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 1.1 |
3.3 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 1.1 |
7.6 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 1.1 |
10.9 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 1.1 |
2.2 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 1.1 |
3.3 |
GO:1902870 |
negative regulation of neural retina development(GO:0061076) negative regulation of retina development in camera-type eye(GO:1902867) negative regulation of amacrine cell differentiation(GO:1902870) |
| 1.1 |
4.3 |
GO:2000660 |
negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 1.1 |
4.3 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 1.1 |
5.4 |
GO:0070586 |
negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 1.1 |
9.7 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 1.1 |
2.1 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 1.1 |
3.2 |
GO:0035702 |
monocyte homeostasis(GO:0035702) |
| 1.1 |
4.3 |
GO:1902303 |
negative regulation of potassium ion export(GO:1902303) |
| 1.1 |
2.1 |
GO:2000568 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 1.1 |
3.2 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 1.1 |
1.1 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 1.1 |
3.2 |
GO:0072049 |
comma-shaped body morphogenesis(GO:0072049) |
| 1.0 |
1.0 |
GO:2000328 |
regulation of T-helper 17 cell lineage commitment(GO:2000328) |
| 1.0 |
4.2 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 1.0 |
1.0 |
GO:0071608 |
macrophage inflammatory protein-1 alpha production(GO:0071608) |
| 1.0 |
2.1 |
GO:2001201 |
regulation of transforming growth factor-beta secretion(GO:2001201) |
| 1.0 |
7.2 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 1.0 |
5.2 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 1.0 |
2.1 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 1.0 |
3.1 |
GO:0046144 |
D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
| 1.0 |
2.1 |
GO:1905154 |
negative regulation of membrane invagination(GO:1905154) |
| 1.0 |
15.4 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 1.0 |
4.1 |
GO:1900120 |
regulation of receptor binding(GO:1900120) |
| 1.0 |
5.1 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 1.0 |
8.1 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 1.0 |
2.0 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 1.0 |
2.0 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 1.0 |
4.0 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 1.0 |
2.0 |
GO:0010958 |
regulation of amino acid import(GO:0010958) |
| 1.0 |
1.0 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 1.0 |
5.0 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 1.0 |
2.0 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 1.0 |
3.0 |
GO:0072720 |
response to dithiothreitol(GO:0072720) |
| 1.0 |
6.9 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 1.0 |
5.0 |
GO:0009912 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 1.0 |
9.9 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 1.0 |
3.0 |
GO:0035926 |
chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 1.0 |
3.9 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 1.0 |
1.0 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
| 1.0 |
2.9 |
GO:0002644 |
negative regulation of tolerance induction(GO:0002644) |
| 1.0 |
2.9 |
GO:0044849 |
estrous cycle(GO:0044849) |
| 1.0 |
2.9 |
GO:0003330 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 1.0 |
7.8 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 1.0 |
4.9 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 1.0 |
1.9 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
| 1.0 |
1.0 |
GO:1904170 |
regulation of bleb assembly(GO:1904170) |
| 1.0 |
6.7 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 1.0 |
13.3 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 1.0 |
1.0 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
| 0.9 |
2.8 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) |
| 0.9 |
0.9 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.9 |
1.9 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.9 |
2.8 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.9 |
2.8 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.9 |
1.9 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
| 0.9 |
5.7 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.9 |
5.7 |
GO:0051987 |
positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.9 |
3.8 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.9 |
3.8 |
GO:0006868 |
glutamine transport(GO:0006868) |
| 0.9 |
5.6 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) |
| 0.9 |
3.7 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.9 |
7.5 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.9 |
0.9 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.9 |
14.9 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.9 |
6.5 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.9 |
11.1 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.9 |
34.2 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.9 |
8.3 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.9 |
5.5 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.9 |
11.0 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.9 |
12.8 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.9 |
4.6 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.9 |
2.7 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.9 |
0.9 |
GO:0007356 |
thorax and anterior abdomen determination(GO:0007356) |
| 0.9 |
5.4 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.9 |
0.9 |
GO:1904057 |
negative regulation of sensory perception of pain(GO:1904057) |
| 0.9 |
3.6 |
GO:1904502 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.9 |
0.9 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.9 |
2.7 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.9 |
16.9 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.9 |
2.7 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.9 |
3.6 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.9 |
2.7 |
GO:0003051 |
angiotensin-mediated drinking behavior(GO:0003051) |
| 0.9 |
7.1 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.9 |
2.6 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.9 |
6.2 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.9 |
2.6 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.9 |
2.6 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.9 |
4.4 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.9 |
0.9 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.9 |
4.4 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.9 |
2.6 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.9 |
29.6 |
GO:0048821 |
erythrocyte development(GO:0048821) |
| 0.9 |
7.8 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.9 |
2.6 |
GO:0014878 |
response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.9 |
2.6 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.9 |
10.4 |
GO:0034242 |
negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
| 0.9 |
3.5 |
GO:1901374 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.9 |
5.2 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.9 |
7.8 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.9 |
39.6 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.9 |
3.4 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.9 |
4.3 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.9 |
0.9 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.9 |
1.7 |
GO:0061355 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.8 |
2.5 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.8 |
4.2 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.8 |
7.6 |
GO:0071231 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
| 0.8 |
2.5 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.8 |
3.4 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.8 |
1.7 |
GO:0002017 |
regulation of blood volume by renal aldosterone(GO:0002017) |
| 0.8 |
6.7 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.8 |
4.2 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.8 |
2.5 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.8 |
4.1 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.8 |
4.9 |
GO:1901977 |
negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.8 |
1.6 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.8 |
4.9 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.8 |
1.6 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.8 |
0.8 |
GO:0048022 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.8 |
1.6 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.8 |
6.5 |
GO:0006735 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.8 |
5.7 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.8 |
2.4 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.8 |
0.8 |
GO:0033082 |
regulation of extrathymic T cell differentiation(GO:0033082) |
| 0.8 |
6.4 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.8 |
5.6 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.8 |
0.8 |
GO:2000412 |
positive regulation of thymocyte migration(GO:2000412) |
| 0.8 |
3.2 |
GO:0002838 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
| 0.8 |
0.8 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.8 |
0.8 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.8 |
16.7 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.8 |
6.4 |
GO:0019249 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
| 0.8 |
0.8 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 0.8 |
6.3 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.8 |
1.6 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 0.8 |
7.9 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.8 |
3.9 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.8 |
10.9 |
GO:1904659 |
glucose transmembrane transport(GO:1904659) |
| 0.8 |
1.6 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 0.8 |
2.3 |
GO:0052203 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.8 |
3.9 |
GO:1904925 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.8 |
0.8 |
GO:0046878 |
positive regulation of saliva secretion(GO:0046878) |
| 0.8 |
1.5 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.8 |
3.1 |
GO:0072738 |
response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.8 |
3.8 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.8 |
2.3 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.8 |
3.1 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.8 |
3.1 |
GO:0036006 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.8 |
9.2 |
GO:1900118 |
negative regulation of execution phase of apoptosis(GO:1900118) |
| 0.8 |
1.5 |
GO:0055096 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.8 |
5.3 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.8 |
5.3 |
GO:0086011 |
membrane repolarization during action potential(GO:0086011) |
| 0.8 |
4.5 |
GO:0033602 |
negative regulation of dopamine secretion(GO:0033602) |
| 0.8 |
2.3 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.8 |
1.5 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.8 |
4.5 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.8 |
3.0 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.8 |
1.5 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.8 |
3.0 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.7 |
1.5 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.7 |
2.2 |
GO:0002238 |
response to molecule of fungal origin(GO:0002238) |
| 0.7 |
0.7 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.7 |
0.7 |
GO:1901662 |
phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.7 |
4.4 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.7 |
0.7 |
GO:0018201 |
peptidyl-glycine modification(GO:0018201) |
| 0.7 |
3.0 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.7 |
4.4 |
GO:1903182 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.7 |
1.5 |
GO:0038183 |
bile acid signaling pathway(GO:0038183) |
| 0.7 |
2.9 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.7 |
2.9 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.7 |
1.5 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
| 0.7 |
2.2 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.7 |
3.7 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.7 |
2.2 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.7 |
1.5 |
GO:0006848 |
pyruvate transport(GO:0006848) |
| 0.7 |
2.2 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.7 |
0.7 |
GO:0048550 |
negative regulation of pinocytosis(GO:0048550) |
| 0.7 |
4.3 |
GO:0061615 |
glycolytic process through fructose-6-phosphate(GO:0061615) |
| 0.7 |
2.2 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.7 |
1.4 |
GO:1900244 |
positive regulation of synaptic vesicle endocytosis(GO:1900244) |
| 0.7 |
13.7 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.7 |
8.6 |
GO:0099625 |
ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
| 0.7 |
5.0 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.7 |
5.8 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.7 |
2.9 |
GO:2000178 |
negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.7 |
2.9 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.7 |
0.7 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.7 |
4.3 |
GO:0034116 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.7 |
2.1 |
GO:2000570 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.7 |
4.3 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.7 |
1.4 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.7 |
0.7 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.7 |
2.1 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.7 |
14.2 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.7 |
2.8 |
GO:0042125 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.7 |
2.8 |
GO:0061622 |
glycolytic process through glucose-1-phosphate(GO:0061622) glycolytic process from galactose(GO:0061623) |
| 0.7 |
0.7 |
GO:0002370 |
natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
| 0.7 |
2.1 |
GO:0042939 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.7 |
2.1 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.7 |
0.7 |
GO:0071321 |
cellular response to cGMP(GO:0071321) |
| 0.7 |
0.7 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.7 |
1.4 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.7 |
12.6 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.7 |
1.4 |
GO:0060686 |
negative regulation of prostatic bud formation(GO:0060686) |
| 0.7 |
2.8 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.7 |
4.2 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.7 |
5.6 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.7 |
0.7 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.7 |
0.7 |
GO:0080144 |
amino acid homeostasis(GO:0080144) |
| 0.7 |
4.2 |
GO:0003253 |
cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
| 0.7 |
2.8 |
GO:0061450 |
trophoblast cell migration(GO:0061450) |
| 0.7 |
1.4 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.7 |
2.8 |
GO:0040030 |
regulation of molecular function, epigenetic(GO:0040030) |
| 0.7 |
2.1 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.7 |
0.7 |
GO:1902460 |
mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.7 |
1.4 |
GO:0072717 |
cellular response to actinomycin D(GO:0072717) |
| 0.7 |
5.5 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.7 |
2.7 |
GO:0002581 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.7 |
2.7 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.7 |
2.0 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.7 |
0.7 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.7 |
2.0 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.7 |
1.4 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.7 |
2.7 |
GO:0002905 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.7 |
2.0 |
GO:0007439 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.7 |
1.4 |
GO:0035666 |
TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
| 0.7 |
8.1 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 0.7 |
3.4 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.7 |
0.7 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.7 |
2.0 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.7 |
1.3 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.7 |
2.0 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.7 |
1.3 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.7 |
0.7 |
GO:1904959 |
regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
| 0.7 |
1.3 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.7 |
0.7 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.7 |
1.3 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.7 |
2.7 |
GO:0051316 |
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
| 0.7 |
1.3 |
GO:0021570 |
rhombomere 4 development(GO:0021570) |
| 0.7 |
2.0 |
GO:0032274 |
gonadotropin secretion(GO:0032274) |
| 0.7 |
0.7 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.7 |
1.3 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.7 |
0.7 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.7 |
0.7 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.7 |
29.8 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.7 |
5.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.7 |
7.2 |
GO:0042693 |
muscle cell fate commitment(GO:0042693) |
| 0.7 |
4.6 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.7 |
4.6 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 0.7 |
2.6 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.7 |
0.7 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.7 |
1.3 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.7 |
2.0 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.7 |
3.9 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.7 |
4.6 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.6 |
1.3 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.6 |
0.6 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.6 |
0.6 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.6 |
4.5 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.6 |
0.6 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.6 |
4.5 |
GO:0033275 |
actin-myosin filament sliding(GO:0033275) |
| 0.6 |
1.3 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.6 |
2.6 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.6 |
0.6 |
GO:1901538 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.6 |
3.2 |
GO:0072674 |
multinuclear osteoclast differentiation(GO:0072674) |
| 0.6 |
0.6 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.6 |
1.9 |
GO:0099526 |
presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.6 |
2.5 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.6 |
5.1 |
GO:0034651 |
cortisol biosynthetic process(GO:0034651) |
| 0.6 |
0.6 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.6 |
1.9 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.6 |
2.5 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.6 |
2.5 |
GO:1904179 |
positive regulation of adipose tissue development(GO:1904179) |
| 0.6 |
1.3 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 0.6 |
4.4 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.6 |
2.5 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.6 |
1.3 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.6 |
6.2 |
GO:0090022 |
regulation of neutrophil chemotaxis(GO:0090022) |
| 0.6 |
1.9 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.6 |
11.2 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.6 |
1.2 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.6 |
16.1 |
GO:0071514 |
genetic imprinting(GO:0071514) |
| 0.6 |
8.0 |
GO:0010529 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.6 |
6.2 |
GO:0051571 |
positive regulation of histone H3-K4 methylation(GO:0051571) |
| 0.6 |
1.8 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.6 |
1.8 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.6 |
1.8 |
GO:0032954 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.6 |
1.8 |
GO:2000668 |
dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
| 0.6 |
1.2 |
GO:1904976 |
response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.6 |
1.2 |
GO:1902896 |
terminal web assembly(GO:1902896) |
| 0.6 |
5.5 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.6 |
1.2 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.6 |
3.0 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.6 |
1.2 |
GO:0014052 |
regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.6 |
2.4 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.6 |
1.2 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.6 |
3.0 |
GO:2000484 |
positive regulation of interleukin-8 secretion(GO:2000484) |
| 0.6 |
10.2 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.6 |
1.2 |
GO:0002339 |
B cell selection(GO:0002339) |
| 0.6 |
3.6 |
GO:0032071 |
regulation of deoxyribonuclease activity(GO:0032070) regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.6 |
1.2 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.6 |
3.6 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.6 |
0.6 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 0.6 |
1.2 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.6 |
3.6 |
GO:1904672 |
regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.6 |
3.6 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.6 |
7.1 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.6 |
3.5 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.6 |
1.8 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.6 |
1.8 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 0.6 |
5.3 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.6 |
1.8 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.6 |
1.2 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.6 |
1.8 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.6 |
6.4 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.6 |
1.2 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.6 |
0.6 |
GO:0072239 |
metanephric glomerulus vasculature development(GO:0072239) |
| 0.6 |
1.2 |
GO:0032056 |
positive regulation of translation in response to stress(GO:0032056) |
| 0.6 |
3.5 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.6 |
1.7 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.6 |
3.5 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.6 |
1.2 |
GO:0060369 |
positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 0.6 |
1.7 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.6 |
3.5 |
GO:0045629 |
negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.6 |
3.4 |
GO:0098909 |
regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.6 |
2.3 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.6 |
5.1 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.6 |
1.1 |
GO:0046502 |
uroporphyrinogen III metabolic process(GO:0046502) |
| 0.6 |
1.1 |
GO:0045605 |
negative regulation of epidermal cell differentiation(GO:0045605) |
| 0.6 |
2.3 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.6 |
1.1 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.6 |
0.6 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.6 |
1.7 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.6 |
4.5 |
GO:0030007 |
cellular potassium ion homeostasis(GO:0030007) |
| 0.6 |
25.5 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.6 |
0.6 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.6 |
0.6 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.6 |
3.4 |
GO:0051590 |
positive regulation of neurotransmitter transport(GO:0051590) |
| 0.6 |
7.3 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
| 0.6 |
1.7 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.6 |
1.1 |
GO:0031179 |
peptide modification(GO:0031179) |
| 0.6 |
0.6 |
GO:0039020 |
pronephric nephron tubule development(GO:0039020) pronephros morphogenesis(GO:0072114) |
| 0.6 |
1.1 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.6 |
6.7 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.6 |
2.2 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.6 |
1.7 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.6 |
2.2 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.6 |
2.2 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.6 |
2.2 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.6 |
2.2 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.6 |
1.7 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.6 |
2.2 |
GO:0036295 |
cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) |
| 0.6 |
7.7 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.6 |
12.2 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.6 |
3.9 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.6 |
3.9 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.6 |
0.6 |
GO:0036257 |
multivesicular body organization(GO:0036257) |
| 0.5 |
2.2 |
GO:0021781 |
glial cell fate commitment(GO:0021781) |
| 0.5 |
1.6 |
GO:2000016 |
negative regulation of determination of dorsal identity(GO:2000016) |
| 0.5 |
1.6 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.5 |
1.1 |
GO:0032252 |
secretory granule localization(GO:0032252) |
| 0.5 |
3.3 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.5 |
1.6 |
GO:0048566 |
embryonic digestive tract development(GO:0048566) |
| 0.5 |
1.6 |
GO:0042339 |
keratan sulfate metabolic process(GO:0042339) |
| 0.5 |
2.2 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.5 |
3.3 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.5 |
9.2 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.5 |
3.8 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.5 |
0.5 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.5 |
3.2 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.5 |
14.0 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.5 |
7.5 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.5 |
3.8 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.5 |
1.6 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.5 |
2.1 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.5 |
2.1 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.5 |
1.6 |
GO:0051459 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.5 |
4.3 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.5 |
3.2 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.5 |
2.1 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.5 |
2.1 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.5 |
2.1 |
GO:0010286 |
heat acclimation(GO:0010286) |
| 0.5 |
4.7 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.5 |
31.9 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.5 |
2.1 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.5 |
0.5 |
GO:0061193 |
taste bud development(GO:0061193) |
| 0.5 |
2.6 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.5 |
3.1 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.5 |
3.1 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.5 |
5.7 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.5 |
1.0 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.5 |
1.0 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.5 |
7.1 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.5 |
1.0 |
GO:1904798 |
positive regulation of core promoter binding(GO:1904798) |
| 0.5 |
1.5 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.5 |
5.1 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.5 |
4.0 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.5 |
4.5 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.5 |
2.5 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.5 |
7.0 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.5 |
2.0 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.5 |
4.0 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.5 |
6.4 |
GO:0002026 |
regulation of the force of heart contraction(GO:0002026) |
| 0.5 |
2.0 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.5 |
1.0 |
GO:2000774 |
positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 0.5 |
1.5 |
GO:0070723 |
response to cholesterol(GO:0070723) cellular response to cholesterol(GO:0071397) |
| 0.5 |
1.5 |
GO:1903632 |
positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.5 |
0.5 |
GO:0019389 |
glucuronoside metabolic process(GO:0019389) |
| 0.5 |
2.0 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.5 |
1.5 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.5 |
5.4 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.5 |
3.4 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.5 |
1.9 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.5 |
2.4 |
GO:0090520 |
sphingolipid mediated signaling pathway(GO:0090520) |
| 0.5 |
0.5 |
GO:0034395 |
regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 0.5 |
1.9 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.5 |
3.4 |
GO:0035872 |
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
| 0.5 |
2.4 |
GO:0033029 |
neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.5 |
2.4 |
GO:0042891 |
antibiotic transport(GO:0042891) |
| 0.5 |
2.4 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.5 |
2.4 |
GO:0033687 |
osteoblast proliferation(GO:0033687) |
| 0.5 |
0.5 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.5 |
1.9 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.5 |
0.9 |
GO:1903556 |
negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
| 0.5 |
1.4 |
GO:1904569 |
regulation of selenocysteine incorporation(GO:1904569) |
| 0.5 |
1.4 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.5 |
1.4 |
GO:1903225 |
regulation of endodermal cell differentiation(GO:1903224) negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.5 |
1.9 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.5 |
4.2 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.5 |
7.0 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.5 |
0.9 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
| 0.5 |
0.5 |
GO:0000448 |
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.5 |
0.5 |
GO:0071287 |
cellular response to manganese ion(GO:0071287) |
| 0.5 |
1.9 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.5 |
1.4 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.5 |
2.3 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.5 |
1.9 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.5 |
5.5 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.5 |
1.4 |
GO:0090306 |
spindle assembly involved in meiosis(GO:0090306) |
| 0.5 |
1.4 |
GO:2000321 |
positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.5 |
0.9 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.5 |
1.8 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.5 |
2.3 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.5 |
2.7 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.5 |
0.9 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.5 |
2.7 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.5 |
4.1 |
GO:0090025 |
regulation of monocyte chemotaxis(GO:0090025) |
| 0.5 |
1.4 |
GO:0003352 |
regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.5 |
5.0 |
GO:1904867 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.5 |
0.9 |
GO:0045915 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.5 |
7.7 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.5 |
7.3 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.5 |
0.5 |
GO:0061402 |
positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
| 0.5 |
0.9 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.5 |
1.8 |
GO:0046946 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.4 |
13.9 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.4 |
1.8 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.4 |
4.5 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.4 |
1.3 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
| 0.4 |
5.8 |
GO:0033363 |
secretory granule organization(GO:0033363) |
| 0.4 |
1.3 |
GO:0032769 |
negative regulation of monooxygenase activity(GO:0032769) |
| 0.4 |
5.8 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.4 |
4.9 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.4 |
0.9 |
GO:0010424 |
DNA methylation on cytosine within a CG sequence(GO:0010424) |
| 0.4 |
4.0 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.4 |
1.3 |
GO:0033189 |
response to vitamin A(GO:0033189) |
| 0.4 |
2.2 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.4 |
8.4 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.4 |
1.8 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.4 |
0.4 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.4 |
0.4 |
GO:0099541 |
trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
| 0.4 |
1.3 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.4 |
4.4 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.4 |
11.4 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.4 |
20.9 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.4 |
0.4 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.4 |
1.3 |
GO:0048865 |
stem cell fate commitment(GO:0048865) stem cell fate specification(GO:0048866) endocardial cell differentiation(GO:0060956) |
| 0.4 |
0.9 |
GO:0045625 |
regulation of T-helper 1 cell differentiation(GO:0045625) |
| 0.4 |
3.5 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.4 |
0.9 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.4 |
1.3 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.4 |
5.6 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.4 |
4.8 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.4 |
1.3 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.4 |
0.9 |
GO:0035744 |
T-helper 1 cell cytokine production(GO:0035744) |
| 0.4 |
0.9 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.4 |
1.7 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.4 |
1.3 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.4 |
5.6 |
GO:0046473 |
phosphatidic acid metabolic process(GO:0046473) |
| 0.4 |
2.1 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.4 |
1.7 |
GO:2001183 |
negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.4 |
1.7 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.4 |
13.6 |
GO:0006335 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.4 |
2.5 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.4 |
0.4 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.4 |
0.8 |
GO:2000020 |
positive regulation of male gonad development(GO:2000020) |
| 0.4 |
2.9 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.4 |
6.3 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.4 |
1.3 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.4 |
1.3 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.4 |
0.8 |
GO:0071372 |
response to follicle-stimulating hormone(GO:0032354) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.4 |
2.1 |
GO:0051974 |
negative regulation of telomerase activity(GO:0051974) |
| 0.4 |
0.4 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.4 |
2.1 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.4 |
0.4 |
GO:0006598 |
polyamine catabolic process(GO:0006598) |
| 0.4 |
7.0 |
GO:0061756 |
leukocyte adhesion to vascular endothelial cell(GO:0061756) |
| 0.4 |
0.8 |
GO:0046351 |
disaccharide biosynthetic process(GO:0046351) |
| 0.4 |
0.8 |
GO:0032735 |
positive regulation of interleukin-12 production(GO:0032735) |
| 0.4 |
0.4 |
GO:1990918 |
double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.4 |
2.0 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 0.4 |
0.4 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.4 |
2.4 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.4 |
1.2 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.4 |
0.4 |
GO:0070171 |
negative regulation of tooth mineralization(GO:0070171) |
| 0.4 |
1.6 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.4 |
1.2 |
GO:0002946 |
tRNA C5-cytosine methylation(GO:0002946) |
| 0.4 |
1.2 |
GO:0044359 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.4 |
0.8 |
GO:0046078 |
dUMP metabolic process(GO:0046078) |
| 0.4 |
0.4 |
GO:0002676 |
regulation of chronic inflammatory response(GO:0002676) |
| 0.4 |
6.3 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.4 |
1.2 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.4 |
2.0 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.4 |
2.7 |
GO:0098719 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.4 |
0.8 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.4 |
1.9 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.4 |
1.2 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.4 |
3.1 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.4 |
0.8 |
GO:0002266 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.4 |
0.8 |
GO:0007060 |
male meiosis chromosome segregation(GO:0007060) |
| 0.4 |
0.8 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.4 |
0.4 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.4 |
1.9 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.4 |
0.4 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.4 |
6.1 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.4 |
0.8 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.4 |
0.4 |
GO:0017185 |
peptidyl-lysine hydroxylation(GO:0017185) |
| 0.4 |
1.5 |
GO:0015855 |
nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
| 0.4 |
0.4 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.4 |
1.5 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.4 |
0.4 |
GO:0060920 |
cardiac pacemaker cell differentiation(GO:0060920) |
| 0.4 |
0.4 |
GO:0019471 |
4-hydroxyproline metabolic process(GO:0019471) |
| 0.4 |
0.4 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.4 |
0.8 |
GO:0048298 |
isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.4 |
5.2 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.4 |
0.7 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.4 |
0.7 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.4 |
0.7 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.4 |
0.7 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.4 |
0.4 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.4 |
6.3 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.4 |
1.5 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.4 |
0.7 |
GO:0031627 |
telomeric loop formation(GO:0031627) |
| 0.4 |
0.7 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.4 |
7.7 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.4 |
0.7 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.4 |
4.1 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.4 |
6.2 |
GO:0071467 |
cellular response to pH(GO:0071467) |
| 0.4 |
3.6 |
GO:1902571 |
regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.4 |
1.8 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.4 |
3.3 |
GO:0030168 |
platelet activation(GO:0030168) |
| 0.4 |
1.5 |
GO:0071043 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.4 |
1.4 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.4 |
1.1 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.4 |
1.8 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.4 |
1.4 |
GO:0032740 |
positive regulation of interleukin-17 production(GO:0032740) |
| 0.4 |
6.1 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.4 |
0.4 |
GO:0072309 |
mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
| 0.4 |
1.4 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.4 |
0.4 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.4 |
4.3 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.4 |
1.4 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.4 |
0.7 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.4 |
1.1 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.4 |
6.4 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.4 |
3.2 |
GO:0032261 |
purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
| 0.4 |
2.5 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.4 |
0.4 |
GO:0060278 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.4 |
3.2 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.3 |
2.1 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.3 |
1.0 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.3 |
7.0 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
| 0.3 |
3.8 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.3 |
9.0 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.3 |
1.0 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) |
| 0.3 |
2.1 |
GO:0098868 |
bone growth(GO:0098868) |
| 0.3 |
0.7 |
GO:0008038 |
neuron recognition(GO:0008038) |
| 0.3 |
0.3 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 0.3 |
0.7 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.3 |
1.4 |
GO:1902167 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
| 0.3 |
1.0 |
GO:0061090 |
positive regulation of sequestering of zinc ion(GO:0061090) |
| 0.3 |
1.4 |
GO:0014820 |
tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
| 0.3 |
1.0 |
GO:1902218 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) |
| 0.3 |
0.7 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.3 |
1.0 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.3 |
0.7 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.3 |
1.0 |
GO:0060561 |
apoptotic process involved in morphogenesis(GO:0060561) |
| 0.3 |
0.3 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.3 |
0.3 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.3 |
4.6 |
GO:0060480 |
lung goblet cell differentiation(GO:0060480) |
| 0.3 |
3.6 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.3 |
2.3 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.3 |
3.3 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.3 |
3.3 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.3 |
1.6 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.3 |
1.3 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.3 |
9.8 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.3 |
1.0 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.3 |
2.0 |
GO:0032202 |
telomere assembly(GO:0032202) |
| 0.3 |
9.8 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.3 |
1.6 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.3 |
3.2 |
GO:0050869 |
negative regulation of B cell activation(GO:0050869) |
| 0.3 |
4.5 |
GO:0006241 |
CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.3 |
0.3 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.3 |
0.6 |
GO:0046075 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.3 |
3.9 |
GO:0046514 |
ceramide catabolic process(GO:0046514) |
| 0.3 |
0.3 |
GO:0014870 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.3 |
1.6 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.3 |
2.2 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.3 |
0.6 |
GO:0002358 |
B cell homeostatic proliferation(GO:0002358) |
| 0.3 |
0.3 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.3 |
0.6 |
GO:0051350 |
negative regulation of lyase activity(GO:0051350) |
| 0.3 |
0.3 |
GO:0002313 |
mature B cell differentiation involved in immune response(GO:0002313) |
| 0.3 |
10.4 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.3 |
0.3 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.3 |
0.3 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.3 |
0.6 |
GO:0043173 |
nucleotide salvage(GO:0043173) |
| 0.3 |
2.2 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.3 |
1.3 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.3 |
0.3 |
GO:0060911 |
cardiac cell fate commitment(GO:0060911) |
| 0.3 |
0.6 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 0.3 |
1.2 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.3 |
0.6 |
GO:0009838 |
abscission(GO:0009838) |
| 0.3 |
1.2 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.3 |
0.3 |
GO:2000317 |
negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.3 |
3.7 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.3 |
0.3 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.3 |
0.3 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.3 |
0.3 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.3 |
3.4 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.3 |
1.8 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.3 |
0.6 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.3 |
3.0 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.3 |
2.1 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.3 |
1.8 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.3 |
0.3 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.3 |
3.0 |
GO:0001502 |
cartilage condensation(GO:0001502) |
| 0.3 |
1.8 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.3 |
0.6 |
GO:1901673 |
regulation of mitotic spindle assembly(GO:1901673) |
| 0.3 |
0.9 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.3 |
0.9 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.3 |
0.6 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.3 |
1.2 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 0.3 |
0.9 |
GO:0021578 |
hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
| 0.3 |
2.4 |
GO:0070236 |
regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.3 |
0.6 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.3 |
7.3 |
GO:0048701 |
embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.3 |
1.8 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) |
| 0.3 |
1.8 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.3 |
1.2 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.3 |
0.9 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.3 |
1.2 |
GO:0051444 |
negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.3 |
3.2 |
GO:0043306 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.3 |
7.0 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.3 |
1.2 |
GO:0009816 |
defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
| 0.3 |
1.5 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.3 |
0.3 |
GO:0042362 |
fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.3 |
0.6 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.3 |
0.3 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.3 |
3.5 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.3 |
2.3 |
GO:0071236 |
cellular response to antibiotic(GO:0071236) |
| 0.3 |
1.2 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.3 |
1.1 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.3 |
0.6 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.3 |
1.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.3 |
0.6 |
GO:0015961 |
diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) |
| 0.3 |
0.3 |
GO:1903978 |
regulation of microglial cell activation(GO:1903978) |
| 0.3 |
7.1 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.3 |
2.0 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.3 |
3.4 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.3 |
2.2 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.3 |
1.4 |
GO:0036476 |
neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.3 |
1.7 |
GO:0002826 |
negative regulation of T-helper 1 type immune response(GO:0002826) |
| 0.3 |
2.8 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.3 |
0.3 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.3 |
4.5 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.3 |
3.6 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.3 |
0.8 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) |
| 0.3 |
1.1 |
GO:0048715 |
negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.3 |
6.1 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.3 |
0.8 |
GO:0002765 |
immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.3 |
0.8 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.3 |
1.6 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.3 |
1.1 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.3 |
1.1 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.3 |
1.4 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.3 |
0.5 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.3 |
0.3 |
GO:0098743 |
cell aggregation(GO:0098743) |
| 0.3 |
1.9 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.3 |
0.5 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
| 0.3 |
0.8 |
GO:0061739 |
protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.3 |
0.5 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.3 |
0.3 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.3 |
0.3 |
GO:0043308 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.3 |
0.3 |
GO:0002579 |
positive regulation of antigen processing and presentation(GO:0002579) |
| 0.3 |
2.4 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.3 |
0.8 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.3 |
1.1 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.3 |
1.3 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.3 |
1.6 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.3 |
2.9 |
GO:0002639 |
positive regulation of immunoglobulin production(GO:0002639) |
| 0.3 |
0.5 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.3 |
0.3 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.3 |
3.1 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.3 |
0.3 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.3 |
1.3 |
GO:1900086 |
regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.3 |
2.1 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.3 |
0.8 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.3 |
2.1 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.3 |
4.1 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.3 |
0.5 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.3 |
1.0 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.3 |
2.3 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.3 |
0.3 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.3 |
1.5 |
GO:0019730 |
antimicrobial humoral response(GO:0019730) |
| 0.3 |
2.3 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.3 |
1.3 |
GO:0002386 |
immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 0.3 |
1.5 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.3 |
0.3 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.3 |
0.3 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.3 |
0.3 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.2 |
1.7 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.2 |
0.2 |
GO:0048880 |
sensory system development(GO:0048880) |
| 0.2 |
0.7 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.2 |
0.2 |
GO:0046719 |
regulation by virus of viral protein levels in host cell(GO:0046719) |
| 0.2 |
0.2 |
GO:0060842 |
arterial endothelial cell differentiation(GO:0060842) |
| 0.2 |
0.2 |
GO:1903514 |
calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
| 0.2 |
0.2 |
GO:0070253 |
somatostatin secretion(GO:0070253) |
| 0.2 |
0.2 |
GO:0034370 |
triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
| 0.2 |
0.5 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.2 |
1.0 |
GO:0009099 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.2 |
1.2 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.2 |
0.5 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.2 |
1.5 |
GO:0042531 |
positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 0.2 |
1.9 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.2 |
0.2 |
GO:0042091 |
interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.2 |
0.7 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.2 |
0.2 |
GO:0071599 |
otic vesicle development(GO:0071599) |
| 0.2 |
3.8 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.2 |
8.0 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.2 |
0.7 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.2 |
1.2 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.2 |
1.9 |
GO:0051255 |
spindle midzone assembly(GO:0051255) |
| 0.2 |
0.5 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.2 |
3.0 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.2 |
0.9 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.2 |
0.7 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 0.2 |
3.2 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.2 |
0.2 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) |
| 0.2 |
2.3 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.2 |
0.5 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.2 |
1.8 |
GO:0043585 |
nose morphogenesis(GO:0043585) alveolar primary septum development(GO:0061143) |
| 0.2 |
0.2 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.2 |
6.6 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.2 |
1.4 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.2 |
0.9 |
GO:1903445 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 |
5.0 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.2 |
3.2 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.2 |
0.5 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.2 |
0.5 |
GO:0045910 |
negative regulation of DNA recombination(GO:0045910) |
| 0.2 |
0.7 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.2 |
0.2 |
GO:0010912 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.2 |
0.9 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.2 |
1.1 |
GO:0009226 |
nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.2 |
0.7 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.2 |
0.7 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.2 |
5.1 |
GO:1902850 |
mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.2 |
0.7 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.2 |
1.3 |
GO:0010166 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.2 |
3.7 |
GO:0032094 |
response to food(GO:0032094) |
| 0.2 |
0.4 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.2 |
1.8 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.2 |
0.7 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.2 |
4.2 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.2 |
0.4 |
GO:0009148 |
pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
| 0.2 |
2.8 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.2 |
2.4 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.2 |
1.1 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.2 |
1.5 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.2 |
0.7 |
GO:1901970 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.2 |
0.4 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.2 |
0.4 |
GO:0014842 |
skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
| 0.2 |
0.9 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.2 |
0.4 |
GO:0021539 |
subthalamus development(GO:0021539) |
| 0.2 |
0.4 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.2 |
0.2 |
GO:0090135 |
actin filament branching(GO:0090135) |
| 0.2 |
0.4 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.2 |
1.3 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.2 |
0.4 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.2 |
1.5 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.2 |
0.8 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.2 |
0.2 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.2 |
1.9 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.2 |
0.6 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.2 |
1.0 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.2 |
0.4 |
GO:0019230 |
proprioception(GO:0019230) |
| 0.2 |
0.6 |
GO:0002385 |
mucosal immune response(GO:0002385) |
| 0.2 |
0.4 |
GO:2000018 |
regulation of male gonad development(GO:2000018) |
| 0.2 |
3.5 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 |
1.0 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.2 |
2.2 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.2 |
2.0 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.2 |
2.6 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 0.2 |
0.6 |
GO:0060440 |
trachea formation(GO:0060440) |
| 0.2 |
1.6 |
GO:0048678 |
response to axon injury(GO:0048678) |
| 0.2 |
1.0 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.2 |
0.8 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.2 |
1.0 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.2 |
0.4 |
GO:0016539 |
intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.2 |
0.4 |
GO:0072683 |
T cell extravasation(GO:0072683) |
| 0.2 |
2.9 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.2 |
1.4 |
GO:0051307 |
meiotic chromosome separation(GO:0051307) |
| 0.2 |
0.2 |
GO:0072401 |
signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.2 |
1.0 |
GO:0060252 |
positive regulation of glial cell proliferation(GO:0060252) |
| 0.2 |
0.2 |
GO:0072244 |
metanephric glomerular epithelium development(GO:0072244) |
| 0.2 |
0.2 |
GO:0072141 |
glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) glomerular mesangial cell development(GO:0072144) |
| 0.2 |
0.6 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.2 |
2.7 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.2 |
1.0 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.2 |
1.1 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.2 |
13.0 |
GO:0002377 |
immunoglobulin production(GO:0002377) |
| 0.2 |
1.7 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 |
4.9 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.2 |
0.2 |
GO:0015965 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.2 |
0.7 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.2 |
0.4 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.2 |
0.6 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.2 |
1.1 |
GO:1901724 |
positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.2 |
2.0 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 |
0.9 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.2 |
0.2 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.2 |
0.5 |
GO:0002741 |
positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.2 |
8.3 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.2 |
0.7 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.2 |
1.3 |
GO:0097210 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.2 |
0.9 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.2 |
1.3 |
GO:0042167 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 |
2.5 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.2 |
1.6 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.2 |
9.8 |
GO:0007586 |
digestion(GO:0007586) |
| 0.2 |
0.4 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.2 |
0.4 |
GO:0002551 |
mast cell chemotaxis(GO:0002551) |
| 0.2 |
0.2 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.2 |
2.4 |
GO:0040036 |
regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
| 0.2 |
0.3 |
GO:0060857 |
establishment of glial blood-brain barrier(GO:0060857) |
| 0.2 |
0.7 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.2 |
1.9 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.2 |
1.0 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 |
1.0 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.2 |
0.7 |
GO:0048563 |
post-embryonic organ morphogenesis(GO:0048563) |
| 0.2 |
0.8 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.2 |
0.2 |
GO:0061308 |
cardiac neural crest cell development involved in heart development(GO:0061308) |
| 0.2 |
2.2 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.2 |
0.2 |
GO:0002827 |
positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.2 |
0.3 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.2 |
0.5 |
GO:1902590 |
viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.2 |
0.5 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 |
0.8 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.2 |
0.5 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.2 |
1.3 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
0.5 |
GO:1904849 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.2 |
1.6 |
GO:1902175 |
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
| 0.2 |
0.2 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.2 |
1.8 |
GO:0031498 |
chromatin disassembly(GO:0031498) |
| 0.2 |
0.2 |
GO:0002525 |
acute inflammatory response to non-antigenic stimulus(GO:0002525) |
| 0.2 |
0.8 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.2 |
6.2 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.2 |
3.3 |
GO:0050829 |
defense response to Gram-negative bacterium(GO:0050829) |
| 0.2 |
0.5 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.2 |
0.8 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.2 |
0.2 |
GO:0002468 |
dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
| 0.2 |
0.2 |
GO:0046476 |
glycosylceramide biosynthetic process(GO:0046476) |
| 0.2 |
0.2 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.2 |
0.8 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 |
0.2 |
GO:1900451 |
positive regulation of glutamate receptor signaling pathway(GO:1900451) |
| 0.2 |
0.5 |
GO:0048023 |
positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
| 0.2 |
1.2 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.2 |
0.5 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.2 |
0.5 |
GO:0097709 |
wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
| 0.2 |
4.4 |
GO:0048704 |
embryonic skeletal system morphogenesis(GO:0048704) |
| 0.2 |
0.2 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 |
2.2 |
GO:0030011 |
maintenance of cell polarity(GO:0030011) |
| 0.1 |
1.0 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
0.1 |
GO:0021544 |
subpallium development(GO:0021544) |
| 0.1 |
1.5 |
GO:0009309 |
amine biosynthetic process(GO:0009309) cellular biogenic amine biosynthetic process(GO:0042401) |
| 0.1 |
0.1 |
GO:0033483 |
oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
| 0.1 |
0.6 |
GO:2001166 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.1 |
0.4 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.1 |
0.7 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 |
7.4 |
GO:0006661 |
phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.1 |
0.6 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.1 |
GO:0086028 |
bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.1 |
0.3 |
GO:0035589 |
G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 |
2.0 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
1.6 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.1 |
1.3 |
GO:0002548 |
monocyte chemotaxis(GO:0002548) |
| 0.1 |
0.7 |
GO:0015669 |
gas transport(GO:0015669) |
| 0.1 |
0.3 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.1 |
2.5 |
GO:0008347 |
glial cell migration(GO:0008347) |
| 0.1 |
0.1 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.4 |
GO:0002355 |
detection of tumor cell(GO:0002355) |
| 0.1 |
0.8 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 |
0.1 |
GO:0046321 |
positive regulation of fatty acid oxidation(GO:0046321) |
| 0.1 |
0.4 |
GO:0006833 |
water transport(GO:0006833) |
| 0.1 |
1.0 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.5 |
GO:2000400 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.1 |
0.1 |
GO:0046813 |
receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.1 |
1.1 |
GO:0048753 |
melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
| 0.1 |
1.5 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.1 |
1.5 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 |
0.5 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
3.1 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.1 |
2.5 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 |
0.4 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.1 |
0.1 |
GO:0010561 |
negative regulation of glycoprotein biosynthetic process(GO:0010561) |
| 0.1 |
0.7 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 |
1.7 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.1 |
1.2 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.1 |
0.5 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.1 |
4.2 |
GO:0015991 |
ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.1 |
5.3 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.1 |
0.6 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.1 |
0.1 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.1 |
0.9 |
GO:0009128 |
purine nucleoside monophosphate catabolic process(GO:0009128) |
| 0.1 |
0.5 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
0.1 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.1 |
0.6 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.1 |
0.4 |
GO:1904645 |
response to beta-amyloid(GO:1904645) |
| 0.1 |
0.2 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
| 0.1 |
3.1 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.1 |
2.2 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
0.1 |
GO:0032736 |
positive regulation of interleukin-13 production(GO:0032736) |
| 0.1 |
0.7 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.1 |
0.5 |
GO:0003266 |
regulation of secondary heart field cardioblast proliferation(GO:0003266) |
| 0.1 |
0.1 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.1 |
0.7 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
3.7 |
GO:0007229 |
integrin-mediated signaling pathway(GO:0007229) |
| 0.1 |
0.1 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.1 |
0.3 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.1 |
0.1 |
GO:0071731 |
response to nitric oxide(GO:0071731) |
| 0.1 |
0.1 |
GO:0009211 |
pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
| 0.1 |
0.6 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 |
0.1 |
GO:0070350 |
white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.1 |
3.9 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.1 |
3.0 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.1 |
0.4 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
1.3 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 |
2.4 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
| 0.1 |
0.9 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.1 |
0.1 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
0.2 |
GO:1904954 |
canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 0.1 |
1.8 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 |
1.0 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.1 |
0.4 |
GO:0034391 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.1 |
0.6 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.1 |
0.1 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 |
1.7 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 0.1 |
0.3 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 |
0.1 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.1 |
0.1 |
GO:0045606 |
positive regulation of epidermal cell differentiation(GO:0045606) |
| 0.1 |
0.2 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.1 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
0.4 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.1 |
0.2 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 |
0.9 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.1 |
0.6 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.9 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.1 |
0.1 |
GO:0048808 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.1 |
0.4 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
5.5 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.1 |
1.5 |
GO:0048536 |
spleen development(GO:0048536) |
| 0.1 |
1.7 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 |
0.6 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.2 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.1 |
0.2 |
GO:0035655 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.1 |
0.3 |
GO:0015881 |
creatine transport(GO:0015881) |
| 0.1 |
0.4 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.1 |
0.4 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.1 |
0.1 |
GO:0002407 |
dendritic cell chemotaxis(GO:0002407) |
| 0.1 |
5.3 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.1 |
0.4 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.1 |
0.2 |
GO:2000659 |
regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.1 |
0.6 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
0.5 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.1 |
2.9 |
GO:0050728 |
negative regulation of inflammatory response(GO:0050728) |
| 0.1 |
0.6 |
GO:0033004 |
negative regulation of mast cell activation(GO:0033004) |
| 0.1 |
0.2 |
GO:0072087 |
renal vesicle development(GO:0072087) |
| 0.1 |
1.5 |
GO:0045576 |
mast cell activation(GO:0045576) |
| 0.1 |
0.7 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.1 |
0.4 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.1 |
1.2 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.1 |
0.4 |
GO:0019086 |
late viral transcription(GO:0019086) |
| 0.1 |
0.1 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.1 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
0.8 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.1 |
0.7 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.3 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
1.4 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.1 |
1.2 |
GO:0002690 |
positive regulation of leukocyte chemotaxis(GO:0002690) |
| 0.1 |
0.1 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.1 |
2.1 |
GO:1901184 |
regulation of ERBB signaling pathway(GO:1901184) |
| 0.1 |
1.1 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 |
0.5 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
1.2 |
GO:0034446 |
substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.1 |
0.2 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.1 |
0.4 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 |
0.5 |
GO:0046102 |
inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
| 0.1 |
0.3 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.2 |
GO:0045655 |
regulation of monocyte differentiation(GO:0045655) |
| 0.1 |
0.8 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
1.6 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
0.2 |
GO:0060847 |
endothelial cell fate specification(GO:0060847) |
| 0.1 |
0.3 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.1 |
0.4 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.1 |
1.0 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.1 |
0.1 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.1 |
0.6 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.1 |
0.9 |
GO:0032925 |
regulation of activin receptor signaling pathway(GO:0032925) |
| 0.1 |
0.5 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 |
0.5 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.1 |
0.7 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
0.4 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.1 |
0.3 |
GO:1990035 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.1 |
0.2 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.1 |
0.3 |
GO:0055075 |
potassium ion homeostasis(GO:0055075) |
| 0.1 |
0.2 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.1 |
0.4 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.1 |
0.1 |
GO:1900222 |
negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.1 |
0.6 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
0.1 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.2 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.1 |
0.6 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.3 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
| 0.1 |
0.1 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.1 |
0.1 |
GO:0050904 |
diapedesis(GO:0050904) |
| 0.1 |
0.2 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 |
1.7 |
GO:0030166 |
proteoglycan biosynthetic process(GO:0030166) |
| 0.1 |
0.2 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.1 |
0.4 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.1 |
0.1 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.0 |
2.8 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.0 |
0.6 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.3 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 |
0.0 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.0 |
0.1 |
GO:0042697 |
menopause(GO:0042697) |
| 0.0 |
0.9 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 |
0.2 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.0 |
0.2 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 |
0.1 |
GO:1903121 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.0 |
0.1 |
GO:0002223 |
stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.0 |
0.1 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.0 |
0.0 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.0 |
0.0 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.0 |
0.2 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.0 |
0.1 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 |
1.1 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.0 |
0.4 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.0 |
0.0 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.0 |
0.1 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
0.0 |
GO:0032240 |
regulation of nucleobase-containing compound transport(GO:0032239) negative regulation of nucleobase-containing compound transport(GO:0032240) regulation of RNA export from nucleus(GO:0046831) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.0 |
0.3 |
GO:1901985 |
positive regulation of protein acetylation(GO:1901985) |
| 0.0 |
0.1 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.0 |
0.1 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 |
0.1 |
GO:0010966 |
regulation of phosphate transport(GO:0010966) |
| 0.0 |
0.0 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.0 |
0.1 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.0 |
0.2 |
GO:0000281 |
mitotic cytokinesis(GO:0000281) |
| 0.0 |
0.4 |
GO:0046596 |
regulation of viral entry into host cell(GO:0046596) |
| 0.0 |
0.0 |
GO:0060368 |
regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.0 |
0.0 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.0 |
0.3 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.0 |
0.1 |
GO:0035815 |
positive regulation of renal sodium excretion(GO:0035815) |
| 0.0 |
0.2 |
GO:0035278 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.1 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.1 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.0 |
0.1 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.0 |
0.1 |
GO:2000234 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 |
0.1 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.0 |
0.0 |
GO:0000239 |
pachytene(GO:0000239) |
| 0.0 |
0.2 |
GO:0030042 |
actin filament depolymerization(GO:0030042) |
| 0.0 |
0.0 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.0 |
0.0 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.0 |
GO:2000273 |
positive regulation of receptor activity(GO:2000273) |
| 0.0 |
0.2 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 |
0.1 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.0 |
0.0 |
GO:0060231 |
mesenchymal to epithelial transition(GO:0060231) |
| 0.0 |
0.1 |
GO:0036481 |
intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.0 |
0.0 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.0 |
0.6 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.0 |
0.1 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.0 |
0.1 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 |
0.0 |
GO:0006244 |
pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.0 |
0.1 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.0 |
0.1 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.0 |
0.0 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.0 |
0.0 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
| 0.0 |
0.1 |
GO:0002716 |
negative regulation of natural killer cell mediated immunity(GO:0002716) |
| 0.0 |
0.1 |
GO:0002418 |
immune response to tumor cell(GO:0002418) |
| 0.0 |
0.1 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.0 |
0.1 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.0 |
0.1 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |